Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure

NCT00843154 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

571

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient enrollment

Conditions

Heart Failure

Interventions

DRUG: Candesartan and standard chronic heart disease therapy
DRUG: Standard chronic heart disease therapy

Sponsor

Takeda